Enzyte
Vianda Enzyte is a 'Botanical with Nutrients' supplement containing 4 ingredients. It received an N+ Score of 66, resulting in a D grade, indicating below-average quality. The product includes Niacin (20 mg), Zinc (15 mg), and Copper (0.9 mg), all of which are present at clinically studied dosages. However, a significant portion of the product is a proprietary blend, the Enzyte Proprietary Blend (638.7 mg), which limits transparency regarding the specific dosages of its botanical components. This lack of transparency makes it difficult to assess the efficacy of the botanical ingredients. This supplement may provide adequate doses of Niacin, Zinc, and Copper, but the overall formulation quality is impacted by the undisclosed blend.
About This Product
Enzyte by Vianda is a vitamins & minerals supplement containing 4 active ingredients. It has earned an N+ Score of 66/100 (Grade D).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Niacin, Zinc, Copper.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +3 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Niacin | 20.000 mg | Optimal |
| Zinc | 15.000 mg | Optimal |
| Copper | 0.900 mg | Optimal |
| Enzyte Proprietary Blend | 638.700 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
